PharmaSphere: New Report Series to Provide 360° Healthcare Industry Insight

Wednesday 17 April 2013, Amsterdam

We are pleased to present PharmaSphere – a new range of reports aimed at arming business professionals within the healthcare industry with the strategic advantage of the most in-depth industry analysis available.

Developed by the research and consulting firm’s specialist Industry Dynamics team, each report in this unique series is designed to instruct and inform clients on the operating environment of a specific segment of the healthcare industry, providing analysis on the key trends driving current and future shifts within that segment.

Joshua Owide, Head of Industry Dynamics Team, says: “The healthcare industry follows an increasingly complex set of rules and we’re looking to provide a comprehensive analysis of the strategies used to promote growth within both internal and external environments and help guide strategic decision making.”

Utilizing the most current data possible, our Industry Dynamics team dissects the landscape of both established and emerging economies to offer expert insights into the challenges and opportunities facing pharmaceutical companies, and how these variables are likely to affect the corporate landscape.

PharmaSphere report subjects will also change year on year, adapting to the feedback and demands of clients and “reflecting the burning issues of the healthcare sector,” explains Owide.

“The series aims to capture many of the strategies at the forefront of corporate decision-making and ensure our clients are equipped to compete in a rapidly evolving industry.”

Reports due to be published in the coming months will focus on a number of areas including generics strategy, biosimilars strategy, academic technology transfer and deal analysis in emerging markets